Literature DB >> 6297832

Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.

R M Rapoport, F Murad.   

Abstract

The present study investigates the hypothesis that endothelium-dependent relaxation of vascular smooth muscle may be mediated through the formation of cGMP. Relaxation of the rat thoracic aorta to acetylcholine, histamine, and Ca++ ionophore A23187 was associated with increased levels of cGMP in a time- and concentration-dependent manner, whereas cAMP levels were unaltered. Removal of the endothelium prevented relaxation to these agents and prevented the increased levels of cGMP. Removal of the endothelium after exposure to acetylcholine only partially decreased the elevated levels of cGMP, suggesting that the changes in cGMP occurred within the smooth muscle cells. Eicosatetraynoic acid, an inhibitor of lipoxygenase and cyclooxygenase, and quinacrine, an inhibitor of phospholipase, prevented and reversed acetylcholine-induced relaxation, respectively, and inhibited acetylcholine-induced increased levels of cGMP. In contrast, sodium nitroprusside-induced relaxation and increased levels of cGMP were independent of the presence of the endothelium, exposure to eicosatetraynoic acid, and quinacrine. The present results support the hypothesis that vascular smooth muscle relaxation induced by some agents is dependent on the presence of the endothelium and is mediated through the formation of an endothelial factor that increases cGMP levels in smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297832     DOI: 10.1161/01.res.52.3.352

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  174 in total

1.  Nitric oxide leads to prized NObility: background to the work of Ferid Murad.

Authors:  T Scott-Burden
Journal:  Tex Heart Inst J       Date:  1999

2.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

3.  Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.

Authors:  Y Jinno; H Kasai; H Ohta; K Nishikori; H Fukushima; N Ogawa
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

4.  Role of nitric oxide in non-adrenergic, non-cholinergic inhibitory junction potentials in canine ileocolonic sphincter.

Authors:  S M Ward; E S McKeen; K M Sanders
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

5.  Cooling and response to adrenoceptor agonists of rabbit ear and femoral artery: role of the endothelium.

Authors:  A L García-Villalón; L Monge; J J Montoya; J L García; N Fernández; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

6.  Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.

Authors:  H Moritoki; T Hisayama; S Takeuchi; H Miyano; W Kondoh
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

7.  Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta.

Authors:  D Lang; M J Lewis
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

8.  Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed.

Authors:  M D Randall; C R Hiley
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

9.  Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels.

Authors:  R Bhardwaj; P K Moore
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

10.  A comparison of the action of the endothelium-derived relaxant factor and the inhibitory factor from the bovine retractor penis on rabbit aortic smooth muscle.

Authors:  A Bowman; J S Gillespie; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.